Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy — Stella
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(3 sites)
United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio
Ohio State University Comprehensive Cancer Center, Columbus, Ohio